Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Author(s): Allen Loyd V Jr
Issue: Jan/Feb 2015 - Volume 19, Number 1
View All Articles in Issue
Page(s): 38-40
Note: Electronic version includes supplemental material.
Download in electronic PDF format for $75
Abstract: The world of pharmaceuticals is changing rapidly as biotechnology continues to grow and nanotechnology appears on the horizon. Biotechnology is gaining in importance in extemporaneous pharmaceutical compounding, and nanotechnology and pharmacogenomics could drastically change the practice of pharmacy. This article discusses biotechnology and the factors to consider when compounding biotechnology drugs.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, biotechnology, cloning, recombinant DNA, recombinant proteins, transgenic organisms, route of administration, peptides, small molecules, excipients, drug carriers
Related Categories: EXCIPIENTS, HISTORY, STABILITIES, COMPATIBILITIES, TECHNOLOGY